Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial - Archive ouverte HAL Access content directly
Journal Articles Lung Cancer Year : 2010

Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial

Nicolas Girard
  • Function : Author
F. Mornex
  • Function : Author
J.-Y. Douillard
  • Function : Author
Nadine Bossard
E. Quoix
  • Function : Author
V. Beckendorf
  • Function : Author
D. Grunenwald
  • Function : Author
E. Amour
  • Function : Author
B. Milleron
  • Function : Author
No file

Dates and versions

hal-00539239 , version 1 (24-11-2010)

Identifiers

  • HAL Id : hal-00539239 , version 1

Cite

Nicolas Girard, F. Mornex, J.-Y. Douillard, Nadine Bossard, E. Quoix, et al.. Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial. Lung Cancer, 2010, 69(1), pp.86-93. ⟨hal-00539239⟩
62 View
0 Download

Share

Gmail Facebook X LinkedIn More